$40.0M
per applicant
Grant
Cash award, application-based
Nov 10, 2026
Apply before this date
Cycle-based
145 days to deadline
Extensive
Detailed federal app
This is a research funding opportunity for scientific studies utilizing expanded access data for investigational drugs or biological products targeting intermediate-sized ALS patient populations. Applicants must be eligible entities registered in SAM.gov and submit applications through Grants.gov by the posted deadline.
Do I qualify?
Answer the questions below to get an instant self-assessment of your fit for this program. This is informational — final determinations are made by the administering agency.
1.Must be an eligible applicant as defined in the opportunity listing
2.SAM.gov registration required prior to application submission
3.Application must be submitted through Grants.gov by posted deadline
4.Research must utilize expanded access data for investigational drugs or biological products
5.Target intermediate size populations of ALS patients
IRS · United States
Allows businesses to deduct up to $5.65/sq ft for commercial buildings achieving significant energy savings through improvements to HVAC, lighting, and building envelope systems. IRA expanded the deduction and allowed non-profits and government to allocate it.
LPO · United States
Offers federal loan guarantees for innovative clean energy projects that struggle to access conventional financing. Supports first-of-kind commercial-scale projects in renewable energy, storage, advanced nuclear, and industrial decarbonization.
CDFI Fund · United States
Attracts private investment into low-income communities by allowing investors to receive a 39% federal tax credit over 7 years on investments made through certified Community Development Entities (CDEs).